8-K

Company

Marker Therapeutics, Inc.

Filed

September 26, 2002

Period of Report

September 23, 2002

Accession Number

0001050502-02-000820

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →